Basal and agonist-stimulated phosphoinositide (PI) turnover and inosit
ol 1,4,5 -trisphospate (InsP(3)) content in rat brain were investigate
d after chronic nicergoline (SERMION(R)) treatment. Oral administratio
n of nicergoline (5 mg/kg b.i.d. for 7 weeks) enhanced the basal turno
ver of PI in the cerebral cortex compared to controls. This effect was
paralleled by a significant rise of cortical InsP(3) levels. No signi
ficant changes of noradrenaline- or carbachol-induced accumulation of
[H-3]-inositol-1-phophate ([H-3]-InsP(1)) were found in cortices from
nicergoline-treated rats. On the contrary, in the striatum nicergoline
significantly potentiated the responsiveness of noradrenaline- and ca
rbachol-stimulated PI turnover, leaving unchanged the basal production
of [H-3]-InsP(1) and InsP(3) levels. The results sug gest that the in
teraction of nicergoline with PI transducing pathway might have releva
nce to the mechanisms of action of nicergoline.